Ko-jiunn T. Liu

No. 367, Sheng Li Road, 704
Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: December 31, 2025

Candida albicans is a context-dependent risk factor for malignant transformation of oral precancer lesions: a prospective cohort study of 734 Taiwanese patients.

Candida albicans is a context-dependent risk factor for malignant transformation of oral precancer lesions: a prospective cohort study of 734 Taiwanese patients.

Journal: Journal of oral microbiology

Published: December 22, 2025

A saliva-based surrogate associates with clinical outcome of oral potentially malignant disorders.

A saliva-based surrogate associates with clinical outcome of oral potentially malignant disorders.

Journal: British journal of cancer

Published: September 14, 2025

Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness.

Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness.

Journal: Journal of proteome research

Published: August 02, 2025

3D culture reveals dual role of ICAM-1 in mediating tissue-specific human MSC spheroid formation & enhanced immunomodulation.

3D culture reveals dual role of ICAM-1 in mediating tissue-specific human MSC spheroid formation & enhanced immunomodulation.

Journal: Biomaterials

Published: July 11, 2025

Quantifying Genetic and Environmental Factors Accounting for Multistage Progression of Precancerous Lesions and Oral Cancer: Applications to Risk-Guided Prevention.

Quantifying Genetic and Environmental Factors Accounting for Multistage Progression of Precancerous Lesions and Oral Cancer: Applications to Risk-Guided Prevention.

Journal: Cancers

Published: May 15, 2025

EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis.

EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis.

Journal: Neoplasia (New York, N.Y.)

Published: February 25, 2025

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Journal: Journal of biomedical science

Published: February 19, 2025

Lack of IFN-γ response of human uterine myometrium-derived MSCs significantly improve multiple IBD parameters compared to bone marrow MSCs: Implications for anti-TNFα-refractory patients.

Lack of IFN-γ response of human uterine myometrium-derived MSCs significantly improve multiple IBD parameters compared to bone marrow MSCs: Implications for anti-TNFα-refractory patients.

Journal: Pharmacological research

Published: February 06, 2025

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases.

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases.

Journal: eLife

Published: January 21, 2025

Phage Display Selected Chicken Antibodies Targeting Surface Alpha Enolase in Staphylococcus aureus.

Phage Display Selected Chicken Antibodies Targeting Surface Alpha Enolase in Staphylococcus aureus.

Journal: Biotechnology journal

Published: November 23, 2024

Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models.

Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models.

Journal: Pharmacological research

Published: June 17, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026